GB1048043A - Benzodioxole derivatives and methods of preparing the same - Google Patents
Benzodioxole derivatives and methods of preparing the sameInfo
- Publication number
- GB1048043A GB1048043A GB4607561A GB4607561A GB1048043A GB 1048043 A GB1048043 A GB 1048043A GB 4607561 A GB4607561 A GB 4607561A GB 4607561 A GB4607561 A GB 4607561A GB 1048043 A GB1048043 A GB 1048043A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- alkyl
- benzodioxoles
- hydrogen
- appropriate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Novel compounds of the formulae <FORM:1048043/C2/1> wherein R1 is NH2, N-(R1)2, N-+(R1)3 (in combination with a pharmaceutically acceptable anion), NH-NH2, NH-CONH2, NH-CO-R1, NH-C(= NH)NH2, piperidino, piperazine or morpholino; R2 is hydrogen or C1- 5 alkyl; R3 is hydrogen or C1- 5 alkyl; R4 is NH-NH2, NH-CO-NH2, NHR1, N(R1)2, piperidino, piperazine or morpholino; and R5, R6, R7 and R8 are hydrogen, halogen, nitro, C1- 5 alkyl, C1- 5 alkoxy or C2- 5 carbalkoxy; R1 being C1- 3 alkyl and each R1 being the same or different in each compound; with the provisos that when in Formula (I) R1 is dimethylamino, diethylamino or piperidino and R2 and R5-R8 are all hydrogen then R3 is not methyl, and when in Formula (II) R3 and R5-R8 are all hydrogen, R4 is not NH-NH2, and acid-addition salts thereof are prepared (1) for the amino compounds, from an appropriate 2-halo-alkyl - 1,3 - benzodioxole and the amine R1H and, if required, quaternizing the product, or reacting it or a salt thereof with a metal cyanate to give the urea compound, or with the anhydride or halide of an acid to give the acylamino compound, or with cyanamide and water to give the guanidino compound; or (2) for the amide compounds, from an appropriate 2 - alkoxycarbonyl - 1,3 - benzodioxole and the amine R,H and, if required, reducing the product to the amines wherein R2 is H; or (3) for the compounds (I), by reacting an appropriate catechol with a compound R3COCH(R2).X wherein X is halogen and replacing the halogen in the product by the basic R1 group; or (4) for the compounds (II), by reacting an appropriate 2 - halocarbonyl - 1,3 - benzodioxole with the compound R4H, or (except when R4 is NHCONH2) reacting the esters used in (3) with the compound R4H. Esters of the formula <FORM:1048043/C2/2> wherein R is C1- 5 alkyl) are prepared from the appropriate catechol and the compound R3CX2.COOR and are converted into 2-halomethyl-1,3-benzodioxoles by reduction to 2 - hydroxymethyl-1,3-benzodioxoles and reaction of these with halogenating agents; and into 2-halocarbonyl-1,3-benzodioxoles by hydrolysis to 2-carboxy-1,3-benzodioxoles and reaction of these with halogenating agents. The benzodioxoles of the invention, which are stated to show antihistaminic, hypotensive, adrenergic nerve and ganglion blocking, adrenolytic, sedative, tranquillizing, anticonvulsant and spasmolytic activity, may be made up into pharmaceutical compositions for oral or parenteral administration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4607561A GB1048043A (en) | 1961-12-22 | 1961-12-22 | Benzodioxole derivatives and methods of preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4607561A GB1048043A (en) | 1961-12-22 | 1961-12-22 | Benzodioxole derivatives and methods of preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1048043A true GB1048043A (en) | 1966-11-09 |
Family
ID=10439749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4607561A Expired GB1048043A (en) | 1961-12-22 | 1961-12-22 | Benzodioxole derivatives and methods of preparing the same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1048043A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2182959A1 (en) * | 1972-04-11 | 1973-12-14 | Istitut Luso Farmaco Italia | |
US5420010A (en) * | 1993-07-30 | 1995-05-30 | Merck & Co., Inc. | Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
-
1961
- 1961-12-22 GB GB4607561A patent/GB1048043A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2182959A1 (en) * | 1972-04-11 | 1973-12-14 | Istitut Luso Farmaco Italia | |
US5420010A (en) * | 1993-07-30 | 1995-05-30 | Merck & Co., Inc. | Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8503666A1 (en) | 1-Aryloxy-2,3,4,5-tetrahydro-3-benzazepines, a process for preparing the same and their use as medicaments. | |
CA2131797A1 (en) | Condensed indole derivatives as 5ht4-receptor antagonists | |
EE9800100A (en) | Condensed tropane derivatives, their preparation and use | |
ES465524A1 (en) | N-(phenylalkylamino-alkyl)-dihydroisoquinolinones, pharmaceutical compositions and methods employing them | |
GB853799A (en) | Diquaternary compounds and process of preparing same | |
ES369934A1 (en) | 3-alkoxy-thia naphthene-2-carboxamides | |
KR900018047A (en) | Substituted Quinazolin Derivatives | |
HUP0203275A2 (en) | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants | |
GB1176173A (en) | Novel Fluorene Compounds | |
GB1048043A (en) | Benzodioxole derivatives and methods of preparing the same | |
ES435929A1 (en) | Process for preparing a thiolcarbamate | |
GB1379940A (en) | Carbazole derivatives | |
GB1420067A (en) | Aryldiamides | |
GB1355718A (en) | 2-amino-5-chloro-thiazole derivatives | |
ES355674A1 (en) | Substituted Anthranilic Acid Amides | |
GB1167711A (en) | Diarylcyclopropane Derivatives | |
GB989627A (en) | New triazolidines and process for preparing them | |
TW340844B (en) | Amide derivatives | |
GB1292417A (en) | 4-amino-2-(5-nitro-2-thienyl) quinazolines, their preparation, and compositions containing them | |
ES368607A1 (en) | 1-substituted-2 5-diphenylpyrroles | |
GB1038729A (en) | New dihydroquinazolines and their preparation | |
ES8606258A1 (en) | 2-(phenylmethylene)-1-(diaminoalkoxy) cycloalkanes and their pharmaceutical uses | |
GB1193534A (en) | Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same | |
GB1042299A (en) | Quinazoline derivatives | |
ES378917A1 (en) | Isoindoline and benzoisothiazoline derivatives, their preparation and pharmaceutical compositions containing them |